Royal Medical Center Review
Best for: Buyers who prioritize a named, credentialed MD founder (Dr. Dagoberto Rodriguez, Emory-trained, 30+ years of practice) and an itemized dose-strength pricing ladder over the lowest-possible monthly cost. Fit for buyers who already need HRT/TRT or a broad peptide adjunct stack and want to consolidate GLP-1 + hormone + peptide programs under one clinic. NOT for buyers who want semaglutide, oral/ODT/troche formats, the lowest cash-pay price (Trimi $99, Coby $99/$179, AVARA $229/$279, Trava are all cheaper), explicit state availability, a named pharmacy partner, a LegitScript badge, or a written refund policy.
Royal Medical Center (royalmedicalcenters.com — 'centers' plural in URL, singular in brand) is a physician-led nationwide telehealth program centered on hormone replacement therapy (HRT/TRT) that also markets a compounded tirzepatide weight-loss program; the storefront is built on WordPress/WooCommerce and Cloudflare blocks direct curl/WebFetch access, so live verification was performed via the Wayback Machine snapshot (Oct 16 2025). Operating brand is 'Royal Medical Center' (operating legal entity / LLC suffix NOT disclosed verbatim on the homepage, about page, or contact page). Founder/medical director is Dr. Dagoberto Rodriguez M.D. (Emory University residency 1990; former chairman, Coral Springs Medical Center 1997-2000; teaching faculty for third-year Family Practice residents at University of Miami School of Medicine since 2004; Vice Chairman at North West Medical Center per the /about/ page) — a strong, verifiable Florida-based physician credentialing footprint that is unusual for a DTC compounded-GLP-1 storefront. Weight-loss program is marketed as 'starting at $116/mo' on the headline banner but the actual compounded-tirzepatide product page itemizes a four-tier monthly ladder: $450 (2.5mg/5mg starting dose, required for all new patients), $650 (7.5mg), $800 (10mg), $1,100 (13mg/15mg), all-inclusive of medication, supplies, injections, lab monitoring, physician consultations, and follow-ups; semaglutide is NOT offered for weight loss (only tirzepatide). Pharmacy partner is not named — homepage only says 'discreetly shipped from the pharmacy to your home or office' and the tirzepatide product meta description says 'US-based Pharmacy.' Adjunct catalog is broad and unusually peptide-heavy: TRT (testosterone-only $89 first-month promo + all-inclusive program), HRT for women (menopausal + non-menopausal estrogen/progesterone), HCG, enclomiphene, clomiphene, sermorelin acetate, CJC/ipamorelin, BPC-157, hexarelin, tesamorelin, GHK-Cu, NAD+, glutathione, lipo-C, PT-141, B-12, B-complex, GAC, sildenafil, tadalafil (daily + as-needed), trimix, scream cream, and a hair regrowth solution (with a separate California-patients SKU). State availability is marketed as 'nationwide' (homepage hero) but no enumerated 50-state list, no state-restriction notice, and no state-specific SKU outside the California hair-regrowth product. Phone 1-800-625-3837. The Cloudflare challenge wall, missing named pharmacy partner, missing operating LLC, missing LegitScript badge, missing itemized state list, and missing refund policy keep this firmly at LOW confidence despite the strong founder-physician credentials.
Low confidence · Last verified 2026-05-28 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Royal Medical Center is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Royal Medical Center prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| 2.5mg/5mg (starting dose) | compounded injection | $450 |
| 7.5mg | compounded injection | $650 |
| 10mg | compounded injection | $800 |
| 13mg/15mg | compounded injection | $1100 |
✓ Pros
- •Strong, verifiable physician founder: Dr. Dagoberto Rodriguez M.D. — Emory University residency, former chairman of Coral Springs Medical Center (1997-2000), Blue Cross Blue Shield peer review committee member, University of Miami School of Medicine teaching faculty since 2004. Unusually strong credentialing vs typical DTC compounded-GLP-1 storefronts.
- •Tirzepatide pricing is fully itemized by dose-strength tier ($450 / $650 / $800 / $1,100) — significantly more transparent than the 'starting at $X' floor common to DTC peers (Trimi, Coby, AVARA Rx all advertise floors only).
- •All-inclusive pricing claim: medication + supplies + injections + lab monitoring + physician consultations + follow-ups bundled at the monthly tier rate (verbatim from /weight-loss/ page).
- •Broad adjunct catalog (HRT, TRT, peptides, ED, hair, vitamins) suggests an established multi-program clinic vs single-product GLP-1 startup.
- •Florida physician footprint + 30+ years of practice history is a positive E-E-A-T signal for buyers prioritizing physician-led care.
✗ Cons
- •Operating legal entity / LLC suffix NOT disclosed verbatim on the homepage, about page, or contact page — only 'Royal Medical Center' brand surfaced.
- •Pharmacy partner NOT named — only generic 'US-based Pharmacy' language on the tirzepatide product page and 'discreetly shipped from the pharmacy' on the homepage. Buyers cannot independently verify the dispensing pharmacy's licensure or 503A/503B status.
- •LegitScript verification badge NOT displayed on the homepage, weight-loss page, or product pages (none of the audited pages surfaced a LegitScript seal).
- •State availability NOT enumerated — site says 'nationwide' but provides no 50-state list or state-restriction notice. The presence of a California-only SKU (hair regrowth) suggests at least some state-specific compliance handling that is not surfaced for the GLP-1 program.
- •Cloudflare challenge wall (HTTP 403 to non-browser User-Agents) prevented direct live verification; this audit relied on a Wayback Machine snapshot from Oct 16 2025, so the data may not reflect the current site state.
- •Headline 'starting at $116/mo' for weight loss is inconsistent with the actual tirzepatide product page floor of $450/mo — the $116 figure likely refers to a different program (possibly testosterone or hormone therapy) and may mislead GLP-1 shoppers.
- •Semaglutide NOT offered for weight loss — tirzepatide-only. Buyers wanting a sema option (cheaper at most DTC peers) must look elsewhere.
- •No semaglutide, no Wegovy, no Zepbound, no Foundayo, no oral/ODT/troche formats — injection-only, single-molecule.
- •Refund / cancellation policy NOT surfaced on the homepage, weight-loss page, or product page.
- •Insurance acceptance NOT addressed — cash-pay model implied but not stated.
- •Lab work requirement: lab monitoring is bundled into the all-inclusive program, but it is unclear whether baseline labs are required before the first shipment or can be drawn after starting therapy.
- •BBB profile NOT found (BBB search for 'royal medical centers' returned zero results as of 2026-05-28).
- •Pricing is mid-to-high tier ($450 floor for tirz) vs the lowest-cost DTC compounded-tirz market ($179-$279 floor at Coby, Trava, AVARA Rx, Trimi).
Ready to start with Royal Medical Center?
Starting at $450/month. See current pricing and start your free consultation.
Sources & methodology
Our Royal Medical Center review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 7.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to Royal Medical Center
Belle Health
Best for: Cost-sensitive patients comfortable with the Feb-2026 FDA warning, wanting flat-rate pricing and dietitian-included support
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-oriented patients who want compounded GLP-1 alongside hormone and performance programs from a 25-year-old established brand
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Royal Medical Center?
Starting at $450/month. See current pricing and start your free consultation.